GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.
GPNMB confers risk for Parkinson's disease through interaction with α-synuclein.
复制标题
DOI:
10.1126/science.abk0637
复制
发表时间:
2022-08-19
期刊:
影响因子:
56.9
通讯作者:
Chen-Plotkin, Alice S.
中科院分区:
文献类型:
--
作者:
Diaz-Ortiz, Maria E.;Seo, Yunji;Posavi, Marijan;Cordon, Marc Carceles;Clark, Elisia;Jain, Nimansha;Charan, Rakshita;Gallagher, Michael D.;Unger, Travis L.;Amari, Noor;Skrinak, R. Tyler;Davila-Rivera, Roseanne;Brody, Eliza M.;Han, Noah;Zack, Rebecca;Van Deerlin, Vivianna M.;Tropea, Thomas F.;Luk, Kelvin C.;Lee, Edward B.;Weintraub, Daniel;Chen-Plotkin, Alice S.
Many risk loci for Parkinson’s disease (PD) have been identified by genome-wide association studies (GWAS), but target genes and mechanisms remain largely unknown. We linked the GWAS-derived chromosome 7 locus (sentinel SNP rs199347) to GPNMB, through colocalization analyses of expression quantitative trait locus (eQTL) and PD risk signals, confirmed by allele-specific expression studies in human brain. In cells, Glycoprotein Nonmetastatic Melanoma Protein B protein (GPNMB) co-immunoprecipitated and co-localized with alpha-synuclein (aSyn). In induced pluripotent stem cell-derived neurons, loss of GPNMB resulted in loss of ability to internalize aSyn fibrils and develop aSyn pathology. In 731 PD and 59 control biosamples, GPNMB was elevated in PD plasma, associating with disease severity. Thus, GPNMB represents a PD risk gene, with potential for biomarker development and therapeutic targeting. Computational, cell biological, and human tissue-based studies establish GPNMB as a risk gene and therapeutic target for PD.
登录
查看更多内容
影响因子:
5.8
作者:
Liberzon, Arthur;Subramanian, Aravind;Mesirov, Jill P.
通讯作者:
Mesirov, Jill P.
DOI:
10.1007/978-1-4939-3572-7_13
发表时间:
2016-01-01
期刊:
DATA MINING TECHNIQUES FOR THE LIFE SCIENCES
影响因子:
--
作者:
Dobin, Alexander;Gingeras, Thomas R.
通讯作者:
Gingeras, Thomas R.
影响因子:
64.8
作者:
GTEx Consortium;Laboratory, Data Analysis &Coordinating Center (LDACC)—Analysis Working Group;Statistical Methods groups—Analysis Working Group;Enhancing GTEx (eGTEx) groups;NIH Common Fund;NIH/NCI;NIH/NHGRI;NIH/NIMH;NIH/NIDA;Biospecimen Collection Source Site—NDRI;Biospecimen Collection Source Site—RPCI;Biospecimen Core Resource—VARI;Brain Bank Repository—University of Miami Brain Endowment Bank;Leidos Biomedical—Project Management;ELSI Study;Genome Browser Data Integration &Visualization—EBI;Genome Browser Data Integration &Visualization—UCSC Genomics Institute, University of California Santa Cruz;Lead analysts:;Laboratory, Data Analysis &Coordinating Center (LDACC):;NIH program management:;Biospecimen collection:;Pathology:;eQTL manuscript working group:;Battle A;Brown CD;Engelhardt BE;Montgomery SB
通讯作者:
Montgomery SB
影响因子:
3.5
作者:
Chen-Plotkin, Alice S.;Geser, Felix;Lee, Virginia M. -Y.
通讯作者:
Lee, Virginia M. -Y.
影响因子:
30.8
作者:
Chang D;Nalls MA;Hallgrímsdóttir IB;Hunkapiller J;van der Brug M;Cai F;International Parkinson's Disease Genomics Consortium;23andMe Research Team;Kerchner GA;Ayalon G;Bingol B;Sheng M;Hinds D;Behrens TW;Singleton AB;Bhangale TR;Graham RR
通讯作者:
Graham RR